2m 2m 2m 2m 2m 2m 2m
EQUILLIUM (EQ)
NASDAQ
$3.13+$0.34 (+12.22%)
Price as of Jun 03, 2026 7:53 PM EDT- $183.4MMarket Cap
- 681.51%1-Year Change
- BiotechnologyIndustry
EQUILLIUM (EQ)
$3.13+$0.34 (+12.22%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 41.1M +13.89% | 36.1M +128.97% | 15.8M N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 -100.00% | 41.1M +13.89% | 36.1M +128.97% | 15.8M N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -12.8M -65.69% | -37.4M +1.05% | -37.0M -1.35% | -37.5M +42.34% | |
Depreciation and Amortization Expense | 116,000 -15.33% | 137,000 +8.73% | 126,000 +6.78% | 118,000 +63.89% | |
Total Operating Expenses | 23.6M -52.12% | 49.4M -2.45% | 50.6M -34.98% | 77.8M +105.99% | |
Operating Profit | -23.6M +185.81% | -8.3M -43.06% | -14.5M -76.61% | -62.1M +64.28% | |
Interest Income | 833,000 -39.68% | 1.4M -40.83% | 2.3M +455.71% | 420,000 +636.84% | |
Interest Expense | N/A N/A | -491,000 0.00% | -491,000 -53.37% | -1.1M -1.86% | |
Interest Income and Expense and Net | 833,000 -6.40% | 890,000 -51.71% | 1.8M +391.15% | -633,000 -37.70% | |
Total Nonoperating Income and Expense | 403,000 +149.27% | -818,000 -146.29% | 1.8M +601.99% | -352,000 -72.20% | |
Income before Taxes | -22.4M +190.66% | -7.7M -39.58% | -12.8M -79.45% | -62.1M +64.28% | |
Income Taxes | 0 -100.00% | 361,000 -37.76% | 580,000 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -22.4M +177.65% | -8.1M -39.51% | -13.3M -78.64% | -62.4M +59.86% | |
Net Income from Continuing Operations Applicable to Common | -22.4M +177.65% | -8.1M -36.75% | -12.8M -79.57% | -62.4M +59.86% | |
Basic EPS and Net Income | -0.39 +69.57% | -0.23 -39.47% | -0.38 -79.46% | -1.85 +36.03% | |
Diluted EPS and Net Income | -0.39 +69.57% | -0.23 -39.47% | -0.38 -79.46% | -1.85 +36.03% | |
Basic Weighted Average Shares | 57.3M +62.07% | 35.4M +1.82% | 34.7M +2.96% | 33.7M +17.09% | |
Diluted Weighted Average Shares | 57.3M +62.07% | 35.4M +1.82% | 34.7M +2.96% | 33.7M +17.09% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 30.3M +67.41% | 18.1M -22.10% | 23.2M -60.72% | 59.1M +17.35% | |
Short-Term Investments | 4.5M 0.00% | 4.5M -74.56% | 17.6M +48.12% | 11.9M -60.73% | |
Cash and Cash Equivalents and Short-Term Investments | 34.8M +54.01% | 22.6M -44.76% | 40.9M -42.46% | 71.0M -12.00% | |
Total Current Assets | 31.0M +24.26% | 25.0M -49.38% | 49.3M -35.69% | 76.7M -7.96% | |
Accumulated Depreciation | 562,000 +12.63% | 499,000 +37.09% | 364,000 +46.18% | 249,000 +69.39% | |
Property and Plant and Equipment and Net | 164,000 -37.40% | 262,000 -16.83% | 315,000 -19.44% | 391,000 +64.98% | |
Total Long-Term Assets | 27,000 -61.43% | 70,000 0.00% | 70,000 -32.69% | 104,000 -32.03% | |
Total Assets | 31.9M +24.54% | 25.6M -49.33% | 50.5M -35.57% | 78.4M -8.18% | |
Income Taxes Payable | 0 -100.00% | 365,000 N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 10.0M +75.01% | 5.7M 0.00% | 5.7M +300.14% | |
Total Current Liabilities | 2.9M -53.84% | 6.4M -76.95% | 27.6M -13.94% | 32.0M +259.37% | |
Total Long-Term Debt | N/A N/A | 0 -100.00% | 3.2M 0.00% | 3.2M -62.98% | |
Total Long-Term Liabilities | 356,000 +90.37% | 187,000 -98.66% | 14.0M -3.05% | 14.4M +26,642.59% | |
Total Liabilities | 3.3M -49.72% | 6.5M -76.60% | 28.0M -39.85% | 46.5M +145.92% | |
Retained Earnings | -216.2M +11.56% | -193.8M +4.34% | -185.7M +7.73% | -172.4M +56.76% | |
Total Stockholders Equity | 28.6M +50.03% | 19.1M -15.56% | 22.6M -29.33% | 31.9M -51.97% | |
Total Shares Outstanding | 61.5M +72.86% | 35.6M +0.86% | 35.3M +2.44% | 34.4M +16.83% | |
Cash Flow | |||||
Cash from Operating Activities | -22.7M +19.55% | -19.0M -12.66% | -21.8M +149.43% | -8.7M -72.78% | |
Capital Expenditures | 48,000 -43.53% | 85,000 +70.00% | 50,000 -82.08% | 279,000 +389.47% | |
Cash from Investing Activities | 4.5M -67.68% | 13.8M +390.09% | -4.8M -125.49% | 18.7M -31.83% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 30.4M +18,453.05% | 164,000 +101.78% | -9.2M +659.51% | -1.2M -103.91% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -20.12% -50.00% | -40.24% -89.78% | -393.91% N/A | |
Return on Assets | -77.92% +267.68% | -21.19% +2.46% | -20.68% -72.86% | -76.21% +66.70% | |
Return on Equity | -93.99% +142.55% | -38.75% -20.79% | -48.92% -61.43% | -126.83% +121.42% | |
Revenue Growth | -100.00% -820.10% | 13.89% -89.23% | 128.97% N/A | N/A N/A | |
Current Ratio | 10.58 +169.19% | 3.93 +119.57% | 1.79 -25.27% | 2.40 -74.39% | |
Cash Ratio | 10.32 +262.68% | 2.85 +237.92% | 0.84 -54.36% | 1.84 -67.34% | |
Debt-to-Equity Ratio | N/A N/A | 0.52 +32.27% | 0.40 +41.49% | 0.28 +83.20% | |
Debt-to-Assets Ratio | N/A N/A | 0.39 +120.43% | 0.18 +55.17% | 0.11 -4.19% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow